There Is a Differential Pattern in the Fatty Acid Profile in Children with CD Compared to Children with UC

• Main Authors: Drozd, A. (Author), Grzybowska-Chlebowczyk, U. (Author), Kikut, J. (Author), Mokrzycka, M. (Author), Szczuko, M. (Author), Ziętek, M. (Author)
• Format: Article
• Language: English
• Published: MDPI 2022
• Subjects: adolescents; Crohn’s disease; fatty acids; gamma linoleic acid; inflammatory bowel disease; lauric acid; linoleic acid; palmitic acid; ulcerative colitis; vaccenic acid
• Online Access: View Fulltext in Publisher

 Background: Crohn’s disease (CD) and Ulcerative Colitis (UC) are classified as inflammatory bowel diseases (IBD). Currently, an increasing number of studies indicate that the metabolic consequences of IBD may include abnormalities in the fatty acid profile. The aim of this study was to compare fatty acid concentrations in IBD in order to identify differences between CD and UC and differences between the phases of both diseases. Methods: Sixty-three adolescent patients with CD (n = 33) and UC (n = 30) aged 13.66 ± 2.67 and 14.15 ± 3.31, respectively, were enrolled in the study. Analysis was performed by gas chromatography. Results: A statistically significant higher concentration of vaccenic acid was observed in the total UC group relative to total CD. In remission CD relative to active CD, a significantly higher concentration of palmitic acid was shown. Whereas in active CD, significantly higher levels of linoleic acid were observed relative to remission. The UC group had significantly higher lauric acid and gamma-linoleic acid levels in active disease relative to remission. Conclusions: The identified differences between FA levels in UC and CD could potentially be involved in the course of both diseases. © 2022 by the authors. Licensee MDPI, Basel, Switzerland.